These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18162625)

  • 1. Intravenous rosuvastatin for acute stroke treatment: an animal study.
    Prinz V; Laufs U; Gertz K; Kronenberg G; Balkaya M; Leithner C; Lindauer U; Endres M
    Stroke; 2008 Feb; 39(2):433-8. PubMed ID: 18162625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice.
    Laufs U; Gertz K; Dirnagl U; Böhm M; Nickenig G; Endres M
    Brain Res; 2002 Jun; 942(1-2):23-30. PubMed ID: 12031849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-ischemic delivery of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor rosuvastatin protects against focal cerebral ischemia in mice via inhibition of extracellular-regulated kinase-1/-2.
    Kilic U; Bassetti CL; Kilic E; Xing H; Wang Z; Hermann DM
    Neuroscience; 2005; 134(3):901-6. PubMed ID: 16009498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-dose rosuvastatin ameliorates lung ischemia-reperfusion injury via upregulation of endothelial nitric oxide synthase and inhibition of macrophage infiltration in rats with pulmonary hypertension.
    Matsuo S; Saiki Y; Adachi O; Kawamoto S; Fukushige S; Horii A; Saiki Y
    J Thorac Cardiovasc Surg; 2015 Mar; 149(3):902-9. PubMed ID: 25454916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of cerebral infarct size by the AT1-receptor blocker candesartan, the HMG-CoA reductase inhibitor rosuvastatin and their combination. An experimental study in rats.
    Engelhorn T; Doerfler A; Heusch G; Schulz R
    Neurosci Lett; 2006 Oct; 406(1-2):92-6. PubMed ID: 16901636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosuvastatin reduces experimental left ventricular infarct size after ischemia-reperfusion injury but not total coronary occlusion.
    Weinberg EO; Scherrer-Crosbie M; Picard MH; Nasseri BA; MacGillivray C; Gannon J; Lian Q; Bloch KD; Lee RT
    Am J Physiol Heart Circ Physiol; 2005 Apr; 288(4):H1802-9. PubMed ID: 15563531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosuvastatin prevents endothelial cell death and reduces atherosclerotic lesion formation in ApoE-deficient mice.
    Enomoto S; Sata M; Fukuda D; Nakamura K; Nagai R
    Biomed Pharmacother; 2009 Jan; 63(1):19-26. PubMed ID: 18162361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral pre-treatment with rosuvastatin protects porcine myocardium from ischaemia/reperfusion injury via a mechanism related to nitric oxide but not to serum cholesterol level.
    Bulhak AA; Gourine AV; Gonon AT; Sjöquist PO; Valen G; Pernow J
    Acta Physiol Scand; 2005 Feb; 183(2):151-9. PubMed ID: 15676056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct vascular and cardioprotective effects of rosuvastatin, a new HMG-CoA reductase inhibitor.
    Jones SP; Gibson MF; Rimmer DM; Gibson TM; Sharp BR; Lefer DJ
    J Am Coll Cardiol; 2002 Sep; 40(6):1172-8. PubMed ID: 12354446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuronal nitric oxide synthase mediates statin-induced restoration of vasa nervorum and reversal of diabetic neuropathy.
    Ii M; Nishimura H; Kusano KF; Qin G; Yoon YS; Wecker A; Asahara T; Losordo DW
    Circulation; 2005 Jul; 112(1):93-102. PubMed ID: 15983249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosuvastatin-regulated post-translational phosphoproteome in human umbilical vein endothelial cells.
    Huang B; Wu CH; Li FA; Liang SS; Shieh YH; Wang LD
    Kaohsiung J Med Sci; 2013 Jul; 29(7):347-52. PubMed ID: 23768697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioprotective effects of low-dose combination therapy with rosuvastatin and fasudil in the isolated rat heart.
    Wu N; Li W; Lv Y; Shu W; Jia D
    Pharmazie; 2014 Sep; 69(9):704-8. PubMed ID: 25272944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of combined treatment with rosuvastatin and protein kinase Cβ2 inhibitor on angiogenesis following myocardial infarction in diabetic rats.
    Huang D; Wang FB; Guo M; Li S; Yan ML; Yu T; Wei M; Li JB
    Int J Mol Med; 2015 Mar; 35(3):829-38. PubMed ID: 25524396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosuvastatin, but not simvastatin, provides end-organ protection in stroke-prone rats by antiinflammatory effects.
    Sironi L; Gianazza E; Gelosa P; Guerrini U; Nobili E; Gianella A; Cremonesi B; Paoletti R; Tremoli E
    Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):598-603. PubMed ID: 15681303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggravation of focal cerebral ischemia by tissue plasminogen activator is reversed by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor but does not depend on endothelial NO synthase.
    Kilic E; Kilic U; Matter CM; Lüscher TF; Bassetti CL; Hermann DM
    Stroke; 2005 Feb; 36(2):332-6. PubMed ID: 15625301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment with rosuvastatin protects against focal cerebral ischemia/reperfusion injury in rats through attenuation of oxidative stress and inflammation.
    Ma M; Uekawa K; Hasegawa Y; Nakagawa T; Katayama T; Sueta D; Toyama K; Kataoka K; Koibuchi N; Kuratsu J; Kim-Mitsuyama S
    Brain Res; 2013 Jun; 1519():87-94. PubMed ID: 23632378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of rosuvastatin on insulin sensitivity in an animal model of insulin resistance: evidence for statin-induced hepatic insulin sensitization.
    Naples M; Federico LM; Xu E; Nelken J; Adeli K
    Atherosclerosis; 2008 May; 198(1):94-103. PubMed ID: 18093597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosuvastatin reduces rat intestinal ischemia-reperfusion injury associated with the preservation of endothelial nitric oxide synthase protein.
    Naito Y; Katada K; Takagi T; Tsuboi H; Kuroda M; Handa O; Kokura S; Yoshida N; Ichikawa H; Yoshikawa T
    World J Gastroenterol; 2006 Apr; 12(13):2024-30. PubMed ID: 16610051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosuvastatin preconditioning provides neuroprotection against spinal cord ischemia in rats through modulating nitric oxide synthase expressions.
    Die J; Wang K; Fan L; Jiang Y; Shi Z
    Brain Res; 2010 Jul; 1346():251-61. PubMed ID: 20513366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of rosuvastatin on ADMA, rhokinase, NADPH oxidase, caveolin-1, hsp 90 and NFkB levels in a rat model of myocardial ischaemia-reperfusion.
    Burma O; Onat E; Uysal A; Ilhan N; Erol D; Ozcan M; Sahna E
    Cardiovasc J Afr; 2014; 25(5):212-6. PubMed ID: 25629537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.